Tafamidis oblong clinical trials

B3461114- A Phase 1, Open-Label, Randomized, Three-Treatment, Three-Period, Crossover, Single Dose Study to Estimate the Relative Bioavailability of 61 mg and 70 mg Tafamidis Free Acid Tablets to Commercial 61 mg Tafamidis Free Acid Capsule Administered Under Fasted Conditions in Healthy Adult Participants

This study is testing new forms of a medicine called tafamidis. It aims to see how well these new forms are absorbed into the body compared to the version already available. This research helps us understand if the new versions might work just as well.